Quantcast

Latest Mesenchymal stem cell Stories

2014-08-29 08:24:07

DALLAS, August 29, 2014 /PRNewswire/ -- Launched June 2014, the "Stem Cell Research Products - Opportunities, Tools, and Technologies" market intelligence report supplies research supply companies with the real-time data necessary to make effective product development decisions, sell effectively to scientists, and take market share from the competition. Full-year 2013 analysis determines the size of the stem cell research products market to be $3.22 billion, and the stem cell...

2014-08-05 08:35:20

The company aims to increase the market penetration of its proprietary MSC-based research products, while expanding its stem cell segment to include differentiated cells derived from MSCs MOUNTAIN VIEW, Calif., Aug. 5, 2014 /PRNewswire/ -- Based on its recent analysis of the stem cell tools and technologies industry, Frost & Sullivan recognizes Vitro Biopharma with the 2014 North American Frost & Sullivan Award for Technology Innovation Leadership. Vitro Biopharma has excelled in the...

2014-07-23 23:13:54

Many current regenerative medicine trials are based on heterologous stem cell transplantation, in which stem cells multiplied from one type of organ or tissue are transferred to treat diseases, disorders, or injuries in a different type of organ or tissue. Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) continues to develop technologies that could allow as well natural, homologous stem cell transplantation therapies for more human organs and tissues. Boston, MA (PRWEB) July 23,...

2014-07-10 08:27:41

SHENZHEN, China, July 10, 2014 /PRNewswire/ -- Beike Biotechnology Co., Ltd. (Beike) has officially been accepted into the approval process for the Chinese Food and Drug Administration for the use of human umbilical cord (UC) derived mesenchymal stem cells (MSCs) for clinical translation and treatment of Systemic Lupus Erythamatosus (SLE). After a recent clinical study was published showing Beike's mesenchymal stem cells effective in treating SLE...

2014-07-01 23:06:24

Medication and minimally invasive surgery to implant a sling can provide relief for millions of people who suffer from stress urinary incontinence (SUI), but not everyone responds to these therapeutic methods. A new study in the current STEM CELLS Translational Medicine tests the safety and effectiveness of stem cells as an alternative SUI treatment. Durham, NC (PRWEB) July 01, 2014 Medication and minimally invasive surgery to implant a sling can provide relief for millions of people who...

2014-07-01 11:00:54

HSC Mesenchymal stem cells have become attractive tools for bioengineers, but some scientists haven’t given up on their regenerative potential Stem cell scientists had what first appeared to be an easy win for regenerative medicine when they discovered mesenchymal stem cells several decades ago. These cells, found in the bone marrow, can give rise to bone, fat, and muscle tissue, and have been used in hundreds of clinical trials for tissue repair. Unfortunately, the results of these...

2014-06-25 08:30:00

Positions Company to Participate in One of the Fastest Growing Areas of Stem Cell Research LAS VEGAS, June 25, 2014 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"), announced today the launch of a new service offering for the isolation and expansion of mesenchymal stem cells through its wholly owned subsidiary CorCell Companies, Inc. (CorCell). This service was researched and developed in CorCell's laboratory...

Embryonic Stem Cells Offer Promising Treatment For Multiple Sclerosis
2014-06-17 03:34:58

University of Connecticut Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease. The researchers demonstrated that the embryonic stem cell therapy significantly reduced MS disease severity in animal models, and offered better treatment results than stem...

2014-06-17 08:28:27

Company to Present at BIO International Convention 2014 LOS ANGELES, June 17, 2014 /PRNewswire/ -- MAX BioPharma (www.maxbiopharma.com)announced today that it has successfully designed and synthesized proprietary small molecule oxysterols that are bone-targeted and possess potent osteogenic activity. The research was conducted as part of MAX BioPharma's first SBIR grant-supported activities in the area of osteoporosis. The company believes that these novel molecules are ideal...

2014-06-05 12:31:31

FARMINGTON, Conn., June 5, 2014 /PRNewswire/ -- ImStem Biotechnology, Inc. (ImStem) announced today it has successfully treated an animal model of multiple sclerosis (MS) using human embryonic stem cells (hESC) derived mesenchymal stem cells (MSCs), called hES-MSCs. Photo - http://photos.prnewswire.com/prnh/20140605/94816Photo - http://photos.prnewswire.com/prnh/20140605/94808 MS is a chronic neuroinflammatory disease with no cure. Most current MS therapies offer only palliative...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'